Teva Pharmaceutical Industries Ltd
TEVA
View Detailed Chart
34.690USD
-0.110-0.32%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
39.80BMarket Cap
28.17P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-0.32%
5 Days
+1.79%
1 Month
+8.03%
6 Months
+116.68%
Year to Date
+11.15%
1 Year
+100.64%
View Detailed Chart
TradingKey Stock Score of Teva Pharmaceutical Industries Ltd
Currency: USD Updated: 2026-02-06Key Insights
Teva Pharmaceutical Industries Ltd's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 45 out of 159 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 35.15.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Teva Pharmaceutical Industries Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative-
Teva Pharmaceutical Industries Ltd Highlights
StrengthsRisks
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PE is 28.17, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 666.08M shares, decreasing 16.96% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 114.00 shares of this stock.
Analyst Rating
Based on
13
analysts
Buy
Current Rating
35.147
Target Price
+1.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Teva Pharmaceutical Industries Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Teva Pharmaceutical Industries Ltd Info
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Ticker SymbolTEVA
CompanyTeva Pharmaceutical Industries Ltd
CEOFrancis (Richard D)
Websitehttps://www.tevapharm.com/
Related Instruments
+3.66%
+3.17%
+0.93%
+1.99%
+1.78%
+1.60%
-0.95%
+4.49%
+2.10%
+10.00%
+2.72%
+4.15%
+1.81%
+4.17%
+0.72%
+1.06%
+2.46%
0.00%
+0.53%
+0.56%Popular Symbols
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
69301.750
-668.380 (-0.95%)
282.580
+22.390 (+8.61%)
2046.440
-5.290 (-0.26%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
